Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery

Clinical and Experimental Immunology

Volumn 184, Issue 2, 2016, Pages 257-263

  Pagowska Klimek I ^a   Swierzko A S ^b   Michalski, M ^b   Glowacka E ^a   Szala Pozdziej A ^b   Sokolowska A ^b   Moll, M ^a   Krajewski, W R ^a   Romak, J ^a   Cedzynski M ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

cardiopulmonary bypass; complement; immunology; inflammation systemic; paediatric

Indexed keywords

COMPLEMENT COMPONENT C4A; LECTIN; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2;

ADOLESCENT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; COMPLEMENT LECTIN PATHWAY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FORWARD HEART FAILURE; HEART SURGERY; HUMAN; INOTROPISM; LEUKOCYTE COUNT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYPNEA;

EID: 84983371372     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12763     Document Type: Article

References (32)

1. Durandy Y. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population. Artif Organs 2014; 38:11–8.
2. Scrascia G, Rotunno C, Guida P et al. Perioperative steroids administration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials. Pediatr Crit Care Med 2014; 15:435–42.
3. Soares LC, Ribas D, Spring R, Silva JM, Miyague NI. Clinical profile of systemic inflammatory response after pediatric cardiac surgery with cardiopulmonary bypass. Arq Bras Cardiol 2010; 94:127–33.
4. Güvener M, Korun O, Demirtürk OS. Risk factors for systemic inflammatory response after congenital cardiac surgery. J Card Surg 2015; 30:92–6.
5. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2006; 81:S2347–54.
6. Stahl GL, Shernan SK, Smith PK, Levy JH. Complement activation and cardiac surgery: a novel target for improving outcomes. Anesth Analg 2012; 115:759–71.
7. Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol 2015; 6:262.
8. Pągowska-Klimek I, Cedzyński M. Mannan-binding lectin in cardiovascular disease. Biomed Res Int 2014; 2014:616817.
9. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17:532–40.
10. Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002; 12:335–52.
11. Cedzyński M, Świerzko AS, Kilpatrick D. Factors of the lectin pathway of complement activation and their clinical associations in neonates. J Biomed Biotechnol 2012; 2012:363246.
12. Marcheix B, Carrier M, Martel C et al. Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg 2008; 85:530–5.
13. Bilgin YM, Brand A, Berger SP. Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion 2008; 48:601–8.
14. Garred P, Strom JJ, Quist L, Taaning E, Madsen HO, Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003; 188:1394–403.
15. Smithson A, Perello R, Aibar J et al. Genotypes coding for low serum levels of mannose-binding lectin are under represented among individuals suffering from noninfectious systemic inflammatory response syndrome. Clin Vaccine Immunol 2010; 17:447–53.
16. Pągowska-Klimek I, Świerzko AS, Michalski M et al. Mannose-binding lectin (MBL) insufficiency protects against the development of systemic inflammatory response after pediatric cardiac surgery. Immunobiology 2016; 221:175–81.
17. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2–8.
18. Gaies MG, Gurney JG, Yen AH et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11:234–8.
19. Hoffman TM, Wernovsky G, Atz AM et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Am Heart J 2002; 143:15–21.
20. Cedzynski M, Szemraj J, Swierzko AS et al. Mannan-binding lectin (MBL) insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004; 136:304–11.
21. Świerzko AS, Szala A, Sawicki S et al. Mannose-binding lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours. Cancer Immunol Immunother 2014; 11:1129–40.
22. Presanis J, Hajela K, Ambrus G, Gal P, Sim RB. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol Immunol 2003; 40:921–9.
23. Hall R. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27:983–1033.
24. Hoedemaekers C, van Deuren M, Sprong T et al. The complement system is activated in a biphasic pattern after coronary artery bypass grafting. Ann Thorac Surg 2010; 89:710–6.
25. Hein E, Munthe-Fog L, Thiara AS, Fiane AE, Mollnes TE, Garred P. Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin pathway in vivo. Clin Exp Immunol 2015; 179:294–9.
26. Seghaye MC, Vasquez-Jimenez J, Qing M et al. Clinical relevance of the systemic inflammatory reaction to cardiac operations in children. In: Baykut D, Krian A, eds. Current perspectives of the extracorporeal circulation. Berlin/Heidelberg: Springer-Verlag, 2000:117–25.
27. Tárnok A, Hambsch J, Emmrich F et al. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol 1999; 20:113–25.
28. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304:497–503.
29. Hetland G, Moen O, Bergh K et al. Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo. Ann Thorac Surg 1997; 63:1076–80.
30. Suzuki Y, Daitoku K, Minakawa M, Fukui K, Fukuda I. Poly-2- methoxyethylacrylate-coated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery. J Artif Organs 2008; 11:111–6.
31. Itoh H, Ichiba S, Ujike Y et al. A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass. Perfusion 2015 Jul 30. pii:0267659115598217. Epub ahead of print.
32. Busche MN, Pavlov V, Takahashi K, Stahl GL. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol 2009; 297:H1853–9.